Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Phase I, Open Label Dose Escalation Study to Evaluate Safety of iHIVARNA-01 in Chronically HIV-infected Patients Under Stable Combined Antiretroviral Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02413645
Recruitment Status : Completed
First Posted : April 10, 2015
Last Update Posted : November 1, 2017
Information provided by (Responsible Party):
Judit Pich Martínez, Fundacion Clinic per a la Recerca Biomédica

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Completed
Actual Primary Completion Date : June 2016
Actual Study Completion Date : October 2016
Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 October 25, 2019
November 14, 2019